Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

<jats:title>ABSTRACT</jats:title> <jats:p> The conjugation of siderophores to antimicrobial molecules is an attractive strategy to overcome the low outer membrane permeability of Gram-negative bacteria. In this Trojan horse approach, the transport of drug conjugates is redirected via TonB-dependent receptors (TBDR), which are involved in the uptake of essential nutrients, including iron. Previous reports have demonstrated the involvement of the TBDRs PiuA and PirA from <jats:named-content content-type="genus-species">Pseudomonas aeruginosa</jats:named-content> and their orthologues in <jats:named-content content-type="genus-species">Acinetobacter baumannii</jats:named-content> in the uptake of siderophore-beta-lactam drug conjugates. By <jats:italic>in silico</jats:italic> screening, we further identified a PiuA orthologue, termed PiuD, present in clinical isolates, including strain LESB58. The <jats:italic>piuD</jats:italic> gene in LESB58 is located at the same genetic locus as <jats:italic>piuA</jats:italic> in strain PAO1. PiuD has a similar crystal structure as PiuA and is involved in the transport of the siderophore-drug conjugates BAL30072, MC-1, and cefiderocol in strain LESB58. To screen for additional siderophore-drug uptake systems, we overexpressed 28 of the 34 TBDRs of strain PAO1 and identified PfuA, OptE, OptJ, and the pyochelin receptor FptA as novel TBDRs conferring increased susceptibility to siderophore-drug conjugates. The existence of a TBDR repertoire in <jats:named-content content-type="genus-species">P. aeruginosa</jats:named-content> able to transport siderophore-drug molecules potentially decreases the likelihood of resistance emergence during therapy. </jats:p>

Original publication

DOI

10.1128/aac.00097-18

Type

Journal article

Journal

Antimicrobial Agents and Chemotherapy

Publisher

American Society for Microbiology

Publication Date

19/03/2018

Volume

62